Brief: Bergenbio Says It Continues Work Towards Upcoming Milestones
29/05/2024 07:07
May 29 (Reuters) - Bergenbio ASA BGBIO.OL :
* OUTLOOK: CO CONTINUES ITS WORK TOWARDS UPCOMING MILESTONES
FOCUSED ON CLINICAL DEVELOPMENT OF BEMCENTINIB WITHIN NSCLC
STK11M
Source text for Eikon: ID:nObiFdVMLa
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee